Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Golden age of rheumatology: Comparing drug-associated risk in pre-biologic era vs. today Rob Volansky
• HHS launches resource series on health effects of climate change Maria Marabito
• Safety in rheumatology, COVID-19 and Evusheld PreP: Where do you stand? Leonard H. Calabrese, DO
• FDA grants efzofitimod orphan drug designation for systemic sclerosis Jason Laday
• Getting Back: Return of in-person meetings stir excitement, ‘a bit of apprehension’ Erich Martin
• Immunocompromised patients ‘continue to battle’ as COVID-19 restrictions ease Erich Martin
• Mark Cuban enters online prescription market ‘nibbling at the edge of transparency’ Rob Volansky
• ‘Risk averse’ rheumatologists report declining JAK use, increased reliance on abatacept Rob Volansky
• Upcoming biosimilar logjam could provide cost savings for arthritis drugs David Statman
• Hooked on Rheum with Max I. Hamburger, MD
• Acute anterior uveitis should prompt screening for axial spondyloarthritis Erich Martin
• Children with lupus at higher COVID-19 hospitalization risk vs. those with JIA Erich Martin
• One-quarter of rheumatology trainees felt unsafe in workplace during COVID-19 Erich Martin
• EULAR/ACR: Complex immunodysregulatory diseases require multidisciplinary approach Erich Martin
• Frailty common in rheumatoid arthritis, predicts mortality, hospitalization Erich Martin
• Gout increases risk for COVID-19-related death Erich Martin
• ‘Large proportion’ of patients with PsA fail to meet treatment targets Erich Martin
• ‘More work to be done’: DMARD use remains low in older adults with rheumatoid arthritis Erich Martin
• Nurse-led education prevents adverse effects in rheumatoid arthritis, SpA treatment Erich Martin
• STAR aims to be ‘gold standard’ for outcome measures in Sjögren’s syndrome Erich Martin
• Subcutaneous tanezumab, NSAIDs improve osteoarthritis pain Erich Martin
• Choice of osteoporosis drug sequence has ‘important clinical consequences’ Rob Volansky
• COVID-19 has caused ‘significant negative impacts’ on patients with musculoskeletal pain Rob Volansky
• ‘Get rid of maintenance prednisone’: Steroid-sparing critical for non-renal lupus Rob Volansky
• Hydroxychloroquine no longer best treatment for systemic dermatomyositis Rob Volansky
• Nasal lavage ‘only way’ to bring vasculitis-related chronic sinusitis under control Rob Volansky
• ‘New tools’ offer hope for diverse gastrointestinal symptoms in systemic sclerosis Rob Volansky
• 'Oft-neglected' Sjögren's syndrome now second most common autoimmune disease Rob Volansky
• ‘The effects of racism’: Patients of color with lupus experience diagnostic delays Rob Volansky